Cargando…
For patients with rheumatic disease and hepatitis C infection: the end of interferon
Hepatitis C virus (HCV) is a global pathogen and is the cause of rare but complex rheumatic complications but more commonly exists as a challenging comorbidity for patients with existing rheumatic diseases. Until recently, the standard of care of HCV has been the use of interferon-based regimens, wh...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613164/ https://www.ncbi.nlm.nih.gov/pubmed/26509045 http://dx.doi.org/10.1136/rmdopen-2014-000008 |